News | January 06, 2026
Nia Therapeutics unveils first implantable brain interface for memory disorders
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
Effectiveness of Covaxin against the Omicron variant is currently being studied
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
Otsuka will pay $700 million to Transcend shareholders at closing, with an additional $525 million in contingent payments tied to future sales milestones
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
Over 8.8?million Indians aged 60 and above currently live with dementia,
The company also revealed that MK-2214 has received Fast Track Designation from the U.S. Food and Drug Administration
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
New study presents a human-relevant stress model for assessing potential therapeutics
Subscribe To Our Newsletter & Stay Updated
